Chimerix, Inc.

Chimerix, Inc.verified

CMRX

Price:

$3.02

Market Cap:

$271.61M

Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat...[Read more]

Industry

Biotechnology

IPO Date

2013-04-11

Stock Exchange

NASDAQ

Ticker

CMRX

The Current Ratio as of December 2024 (TTM) for Chimerix, Inc. (CMRX) is 6.33

According to Chimerix, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.33. This represents a change of -21.15% compared to the average of 8.03 of the last 4 quarters.

Chimerix, Inc. (CMRX) Historical Current Ratio (quarterly & annually)

How has CMRX Current Ratio performed in the past?

The mean historical Current Ratio of Chimerix, Inc. over the last ten years is 12.21. The current 6.33 Current Ratio has changed 5.09% with respect to the historical average. Over the past ten years (40 quarters), CMRX's Current Ratio was at its highest in in the September 2016 quarter at 26.45. The Current Ratio was at its lowest in in the June 2022 quarter at 2.18.

Quarterly (TTM)
Annual

Average

12.21

Median

11.60

Minimum

3.20

Maximum

23.40

Chimerix, Inc. (CMRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Chimerix, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 248.72%

Maximum Annual Current Ratio = 23.40

Minimum Annual Increase = -66.51%

Minimum Annual Current Ratio = 3.20

Quarterly (TTM)
Annual
YearCurrent RatioChange
202310.25-8.24%
202211.18248.72%
20213.20-66.51%
20209.57-25.22%
201912.80-12.42%
201814.6123.18%
201711.86-49.31%
201623.40106.35%
201511.34-18.49%
201413.9125.66%

Chimerix, Inc. (CMRX) Average Current Ratio

How has CMRX Current Ratio performed in the past?

The current Current Ratio of Chimerix, Inc. (CMRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.21

5-year avg

9.40

10-year avg

12.21

Chimerix, Inc. (CMRX) Current Ratio vs. Peers

How is CMRX’s Current Ratio compared to its peers?

Chimerix, Inc.’s Current Ratio is greater than Assembly Biosciences, Inc. (2.36), greater than Spero Therapeutics, Inc. (2.68), greater than Achilles Therapeutics plc (6.04), less than Instil Bio, Inc. (12.90), less than Neoleukin Therapeutics, Inc. (15.33), greater than CytomX Therapeutics, Inc. (1.04), less than NextCure, Inc. (9.07), less than Day One Biopharmaceuticals, Inc. (14.62), greater than X4 Pharmaceuticals, Inc. (4.89), greater than Mereo BioPharma Group plc (6.10), less than Terns Pharmaceuticals, Inc. (32.99),

Build a custom stock screener for Chimerix, Inc. (CMRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chimerix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chimerix, Inc. (CMRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chimerix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Chimerix, Inc.'s Current Ratio?

How is the Current Ratio calculated for Chimerix, Inc. (CMRX)?

What is the highest Current Ratio for Chimerix, Inc. (CMRX)?

What is the 3-year average Current Ratio for Chimerix, Inc. (CMRX)?

What is the 5-year average Current Ratio for Chimerix, Inc. (CMRX)?

How does the current Current Ratio for Chimerix, Inc. (CMRX) compare to its historical average?